Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SoftOx Solutions AS Investor Presentation 2021

Nov 8, 2021

3747_rns_2021-11-08_942445c0-4a47-4284-8071-3d8da507047e.html

Investor Presentation

Open in viewer

Opens in your device viewer

SoftOx Solutions AS: Invitation to Strategy and Capital Markets Day, including Q3 2021 results

SoftOx Solutions AS: Invitation to Strategy and Capital Markets Day, including Q3 2021 results

SoftOx Solutions AS is pleased to invite investors, analysts and other stakeholders to our Strategy and Capital Markets Day, including Q3 2021 results on Wednesday the 17th of November 2021 at 09.00 to 12.00 (CET).

Schedule:

09.00-09.10 Opening with CEO Geir Almås

09.10-10.00 Technology platform and business strategy

10.00-11.30 Program areas for development

11.30-11.45 Finance

11.45-12.00 Q&A

The event will be held in-person at Technopolis, Martin Linges Vei 25, 1364 Fornebu, Norway. It will also be streamed live.

Please register for the event, before 15th of November 2021, by sending an email to [email protected]

The Q3 2021 results will be released at 07:00 (CET) on Wednesday November 17, 2021. The interim report and related materials will be made available on: https://soft-ox.com/financial-calendar-reports/.

For further information, please contact:

CEO Geir Almås of SoftOx Solutions AS, or

CFO Kristine Mundal Rød of SoftOx Solutions AS

Mail: [email protected]

Mobile: (+47) 948 59 599

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian

BioTech company based in Oslo with the aim of helping to combat major threats to

human health, namely the emergence of antimicrobial resistance (AMR), biofilm

infections in chronic wounds and the spread of viruses. For more information on

SoftOx, visit www.soft-ox.com